$5.70
7.10% today
Nasdaq, Apr 04, 09:18 pm CET
ISIN
KYG596651029
Symbol
MGTX
Sector
Industry

MeiraGTx Holdings plc Stock price

$6.13
-0.35 5.40% 1M
+2.03 49.51% 6M
+0.04 0.66% YTD
+0.70 12.89% 1Y
-8.01 56.65% 3Y
-5.70 48.18% 5Y
-8.87 59.13% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.23 3.62%
ISIN
KYG596651029
Symbol
MGTX
Sector
Industry

Key metrics

Market capitalization $483.38m
Enterprise Value $464.52m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 13.96
P/S ratio (TTM) P/S ratio 14.52
P/B ratio (TTM) P/B ratio 7.09
Revenue growth (TTM) Revenue growth 137.42%
Revenue (TTM) Revenue $33.28m
EBIT (operating result TTM) EBIT $-164.21m
Free Cash Flow (TTM) Free Cash Flow $-109.45m
Cash position $103.66m
EPS (TTM) EPS $-2.13
P/E forward negative
P/S forward 3.49
EV/Sales forward 3.36
Short interest 3.40%
Show more

Is MeiraGTx Holdings plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

MeiraGTx Holdings plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a MeiraGTx Holdings plc forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a MeiraGTx Holdings plc forecast:

Buy
100%

Financial data from MeiraGTx Holdings plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
33 33
137% 137%
100%
- Direct Costs 37 37
167% 167%
110%
-3.34 -3.34
1,252% 1,252%
-10%
- Selling and Administrative Expenses 29 29
46% 46%
87%
- Research and Development Expense 119 119
15% 15%
358%
-151 -151
23% 23%
-455%
- Depreciation and Amortization 13 13
7% 7%
39%
EBIT (Operating Income) EBIT -164 -164
20% 20%
-493%
Net Profit -148 -148
76% 76%
-444%

In millions USD.

Don't miss a Thing! We will send you all news about MeiraGTx Holdings plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MeiraGTx Holdings plc Stock News

Positive
Seeking Alpha
10 days ago
MeiraGTx (MGTX) develops gene therapies for ocular diseases, Parkinson's Disease, and xerostomia, with multiple assets in advanced clinical stages showing promising efficacy and safety data. MGTX uses AAV5 capsid vectors and riboswitch technology to deliver gene therapies, aiming for safer and more controlled treatments compared to earlier approaches. Financially, MGTX has a strong cash positio...
Neutral
GlobeNewsWire
22 days ago
-  Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in capital committed to initially focus on expediting Phase 3 clinical development of AAV-GAD for Parkinson's disease -  MeiraGTx and Hologen have created the first neuro-AI clinical drug developm...
Neutral
GlobeNewsWire
22 days ago
- MeiraGTx to receive $200 million in upfront cash consideration - MeiraGTx and Hologen will form a joint venture, Hologen Neuro AI Ltd, with an additional $230 million committed capital from Hologen to fund 100% of the development of AAV-GAD for Parkinson's disease through to commercialization, as well as other potential pipeline products - MeiraGTx will enter into clinical and commercial supp...
More MeiraGTx Holdings plc News

Company Profile

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Alexandria Forbes
Employees 381
Founded 2015
Website www.meiragtx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today